Drug maker posts scientific studies
As promised, drug maker GlaxoSmithKline today began posting summaries of clinical trials of its products on its web site.
The first summaries posted are on Avandia (generic name: rosiglitazone
maleate), a drug for type 2 diabetes.
The company told the New York Times that assembling and preparing the data for posting took 30 people about one month.
Posted by Carla :: 09:48 AM Sep 1
